FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2341351795> ?p ?o ?g. }

• W2341351795 endingPage "182" @default.
• W2341351795 startingPage "170" @default.
• W2341351795 abstract "<b><i>Background/Aims:</i></b> A key issue in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is early identification and prediction of disease progression. Clinical evaluation and imaging are limited due to the lack of sensitivity and disease indolence. We assessed the NETest as a predictive and prognostic marker of progression in a long-term follow-up study. <b><i>Methods:</i></b> GEP-NETs (n = 34) followed for a median 4 years (2.2-5.4) were evaluated. WHO tumor grade/stage grade 1: n = 17, grade 2: n = 14, grade 3: n = 1 (for 2, no grade was available); 31 (91%) were stage IV. Baseline and longitudinal imaging and blood biomarkers were available in all, and progression was defined per standard clinical protocols (RECIST 1.0). The NETest was measured by quantitative PCR of blood and multianalyte algorithmic analysis (disease activity scaled 0-100% with low <40% and high activity risk cutoffs >80%); chromogranin A (CgA) was measured by radioimmunoassay (normal <150 µg/l); progression-free survival (PFS) was analyzed by Cox proportional-hazard regression and Kaplan-Meier analysis. <b><i>Results:</i></b> At baseline, 100% were NETest positive, and CgA was elevated in 50%. The only baseline variable (Cox modeling) associated with PFS was NETest (hazard ratio = 1.022, 95% confidence interval = 1.005-1.04; p < 0.012). Using Kaplan-Meier analyses, the baseline NETest (>80%) was significantly associated (p = 0.01) with disease progression (median PFS 0.68 vs. 2.78 years with <40% levels). The NETest was more informative (96%) than CgA changes (<under>></under>25%) in consistently predicting disease alterations (40%, p < 2 × 10^-5, &#x03C7;² = 18). The NETest had an earlier time point change than imaging (1.02 ± 0.15 years). Baseline NETest levels >40% in stable disease were 100% prognostic of disease progression versus CgA (&#x03C7;² = 5, p < 0.03). Baseline NETest values <40% accurately (100%) predicted stability over 5 years (p = 0.05, &#x03C7;² = 3.8 vs. CgA). <b><i>Conclusion:</i></b> The NETest correlated with a well-differentiated GEP-NET clinical status. The NETest has predictive and prognostic utility for GEP-NETs identifying clinically actionable alterations ∼1 year before image-based evidence of progression." @default.
• W2341351795 created "2016-06-24" @default.
• W2341351795 creator A5009119423 @default.
• W2341351795 creator A5030580928 @default.
• W2341351795 creator A5048652672 @default.
• W2341351795 creator A5055143638 @default.
• W2341351795 creator A5062424480 @default.
• W2341351795 creator A5065549677 @default.
• W2341351795 date "2016-04-15" @default.
• W2341351795 modified "2023-10-14" @default.
• W2341351795 title "NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive" @default.
• W2341351795 cites W1559766992 @default.
• W2341351795 cites W1893885577 @default.
• W2341351795 cites W1933744344 @default.
• W2341351795 cites W1963249638 @default.
• W2341351795 cites W1968842095 @default.
• W2341351795 cites W1972564329 @default.
• W2341351795 cites W1980316717 @default.
• W2341351795 cites W1988232503 @default.
• W2341351795 cites W1998041089 @default.
• W2341351795 cites W1998496809 @default.
• W2341351795 cites W2006821285 @default.
• W2341351795 cites W2008746356 @default.
• W2341351795 cites W2014971874 @default.
• W2341351795 cites W2018913523 @default.
• W2341351795 cites W2019607817 @default.
• W2341351795 cites W2023481027 @default.
• W2341351795 cites W2028618819 @default.
• W2341351795 cites W2038523265 @default.
• W2341351795 cites W2039463805 @default.
• W2341351795 cites W2065528310 @default.
• W2341351795 cites W2071901162 @default.
• W2341351795 cites W2073057620 @default.
• W2341351795 cites W2073504442 @default.
• W2341351795 cites W2074121391 @default.
• W2341351795 cites W2074437049 @default.
• W2341351795 cites W2086374856 @default.
• W2341351795 cites W2088907162 @default.
• W2341351795 cites W2088942535 @default.
• W2341351795 cites W2092262615 @default.
• W2341351795 cites W2094636385 @default.
• W2341351795 cites W2095675262 @default.
• W2341351795 cites W2098042868 @default.
• W2341351795 cites W2101162387 @default.
• W2341351795 cites W2107721849 @default.
• W2341351795 cites W2117668987 @default.
• W2341351795 cites W2117692326 @default.
• W2341351795 cites W2122196655 @default.
• W2341351795 cites W2124727142 @default.
• W2341351795 cites W2125272092 @default.
• W2341351795 cites W2130854041 @default.
• W2341351795 cites W2132550938 @default.
• W2341351795 cites W2154941270 @default.
• W2341351795 cites W2165232124 @default.
• W2341351795 cites W2166499874 @default.
• W2341351795 cites W2167407589 @default.
• W2341351795 cites W2167834420 @default.
• W2341351795 cites W2200909646 @default.
• W2341351795 cites W2289369916 @default.
• W2341351795 cites W2314203637 @default.
• W2341351795 cites W2322936173 @default.
• W2341351795 cites W2460582832 @default.
• W2341351795 cites W4239433453 @default.
• W2341351795 doi "https://doi.org/10.1159/000446025" @default.
• W2341351795 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27078712" @default.
• W2341351795 hasPublicationYear "2016" @default.
• W2341351795 type Work @default.
• W2341351795 sameAs 2341351795 @default.
• W2341351795 citedByCount "82" @default.
• W2341351795 countsByYear W23413517952016 @default.
• W2341351795 countsByYear W23413517952017 @default.
• W2341351795 countsByYear W23413517952018 @default.
• W2341351795 countsByYear W23413517952019 @default.
• W2341351795 countsByYear W23413517952020 @default.
• W2341351795 countsByYear W23413517952021 @default.
• W2341351795 countsByYear W23413517952022 @default.
• W2341351795 countsByYear W23413517952023 @default.
• W2341351795 crossrefType "journal-article" @default.
• W2341351795 hasAuthorship W2341351795A5009119423 @default.
• W2341351795 hasAuthorship W2341351795A5030580928 @default.
• W2341351795 hasAuthorship W2341351795A5048652672 @default.
• W2341351795 hasAuthorship W2341351795A5055143638 @default.
• W2341351795 hasAuthorship W2341351795A5062424480 @default.
• W2341351795 hasAuthorship W2341351795A5065549677 @default.
• W2341351795 hasBestOaLocation W23413517951 @default.
• W2341351795 hasConcept C126322002 @default.
• W2341351795 hasConcept C143998085 @default.
• W2341351795 hasConcept C146357865 @default.
• W2341351795 hasConcept C151730666 @default.
• W2341351795 hasConcept C204232928 @default.
• W2341351795 hasConcept C207103383 @default.
• W2341351795 hasConcept C2779066768 @default.
• W2341351795 hasConcept C44249647 @default.
• W2341351795 hasConcept C50382708 @default.
• W2341351795 hasConcept C71924100 @default.
• W2341351795 hasConcept C77231918 @default.
• W2341351795 hasConcept C86803240 @default.
• W2341351795 hasConcept C90924648 @default.

• next